Tag: Cara Therapeutics (NASDAQ:CARA)

Cannabis Cancer Stock Up 207% In 2017

Posted on by The INO.com Team

Analysis originally distributed on July 19, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis is a proven treatment for cancer patients struggling with the side effects of chemotherapy such as nausea and loss of appetite.

But now, pre clinical research is showing that cannabis could actually be a cancer killer.

A group of scientists recently reported that THC and CBD slowed the growth and even killed certain cancer cells – including breast, brain and liver cancer – when grown in a lab.

Animal studies also suggest that cannabis could be a cancer killer.

A study conducted by Complutense University, one of the oldest and largest universities in Europe located in Madrid, showed that an injection of a synthetic THC eliminated malignant brain tumors in 1/3 of the rats studied while extending the life of another 1/3. Continue reading "Cannabis Cancer Stock Up 207% In 2017" →

North American Cannabis Stock Index Already Up 5% In 2017

Posted on by The INO.com Team

Analysis originally distributed on February 8, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis stocks are off to a good start in 2017.

After gaining 4.2% in January, the MJIC North American Cannabis Stock Index is now up more than 5% on the year.

Although that’s a great return for any ‘normal’ stock index, it might not jump off the page after cannabis stocks delivered big returns in 2016.

However, looking below the surface, you’ll see plenty of cannabis stocks have been burning up the charts in 2017.

Canadian cannabis stocks have been leading the pack.

Canopy Growth Corp (TSX:WEED), Canada’s largest medical cannabis company, is up 25% in 2017.

That bullish movement has been driven by a steady stream of good news. Continue reading "North American Cannabis Stock Index Already Up 5% In 2017" →